ArticleOncoTargets and therapy2020
Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer.
Linlin Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it